Form 4 for IDXX Idexx Laboratories
Accepted 2023-08-08 00:00:00 ET · period of report 2023-08-05 · accession 0000874716-23-000107 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-08 | 2023-08-05 | IDXX | MCKEON BRIAN P | EVP, CFO, Treas | M - OptEx | $0.00 | +192 | 29.8K | +0.6% | $0 |
| D | 2023-08-08 | 2023-08-05 | IDXX | MCKEON BRIAN P | EVP, CFO, Treas | F - Tax | $504.08 | -117 | 29.7K | -0.4% | -$59.0K |
| D | 2023-08-08 | 2023-08-05 | IDXX | MCKEON BRIAN P | EVP, CFO, Treas | M - OptEx | — | -192 | 3,704 | -5% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-05 | M | A | 192 | $0.00 | 29,809.35 | D | — | — | (F1) Includes 12 shares purchased under the Issuer's Employee Stock Purchase Plan on June 30, 2023. |
| 2 | Common | Common Stock | 2023-08-05 | F | D | 117 | $504.08 | 29,692.35 | D | — | — | (F2) Closing price of Issuer common stock on NASDAQ market on August 4, 2023. |
| 3 | Derivative | Restricted Stock Unit | 2023-08-05 | M | D | 192 | — | 3,704 | D | — · — to — | 192 Common Stock | (F4) Not applicable. (F3) Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning August 5, 2020. |